CTLA4 and neoplasm: APCs define the T cell differentiation and activation through tumor antigen presentation on MHC molecules to T cell receptors (TCR), expression of CD80 and CD86 ligands, which bind to co-receptors (such as CD28, ICOS, PD-1, CTLA4), and secretion of specific cytokines that define the fate of T cell differentiation (213).